Literature DB >> 22290358

MicroRNA control of bone formation and homeostasis.

Jane B Lian1, Gary S Stein, Andre J van Wijnen, Janet L Stein, Mohammad Q Hassan, Tripti Gaur, Ying Zhang.   

Abstract

MicroRNAs (miRNAs) repress cellular protein levels to provide a sophisticated parameter of gene regulation that coordinates a broad spectrum of biological processes. Bone organogenesis is a complex process involving the differentiation and crosstalk of multiple cell types for formation and remodeling of the skeleton. Inhibition of mRNA translation by miRNAs has emerged as an important regulator of developmental osteogenic signaling pathways, osteoblast growth and differentiation, osteoclast-mediated bone resorption activity and bone homeostasis in the adult skeleton. miRNAs control multiple layers of gene regulation for bone development and postnatal functions, from the initial response of stem/progenitor cells to the structural and metabolic activity of the mature tissue. This Review brings into focus an emerging concept of bone-regulating miRNAs, the evidence for which has been gathered largely from in vivo mouse models and in vitro studies in human and mouse skeletal cell populations. Characterization of miRNAs that operate through tissue-specific transcription factors in osteoblast and osteoclast lineage cells, as well as intricate feedforward and reverse loops, has provided novel insights into the supervision of signaling pathways and regulatory networks controlling normal bone formation and turnover. The current knowledge of miRNAs characteristic of human pathologic disorders of the skeleton is presented with a future goal towards translational studies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22290358      PMCID: PMC3589914          DOI: 10.1038/nrendo.2011.234

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  152 in total

1.  MicroRNA hsa-miR-138 inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells through adenovirus EID-1.

Authors:  Zhuo Yang; Chunjing Bian; Hong Zhou; Shan Huang; Shihua Wang; Lianming Liao; Robert Chunhua Zhao
Journal:  Stem Cells Dev       Date:  2010-10-07       Impact factor: 3.272

2.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

3.  Specific microRNAs are preferentially expressed by skin stem cells to balance self-renewal and early lineage commitment.

Authors:  Liang Zhang; Nicole Stokes; Lisa Polak; Elaine Fuchs
Journal:  Cell Stem Cell       Date:  2011-03-04       Impact factor: 24.633

4.  Runx2 in normal tissues and cancer cells: A developing story.

Authors:  Karen Blyth; Francois Vaillant; Alma Jenkins; Laura McDonald; Marie Anne Pringle; Camille Huser; Torsten Stein; James Neil; Ewan R Cameron
Journal:  Blood Cells Mol Dis       Date:  2010-06-26       Impact factor: 3.039

5.  Dicer activity in neural crest cells is essential for craniofacial organogenesis and pharyngeal arch artery morphogenesis.

Authors:  Xuguang Nie; Qin Wang; Kai Jiao
Journal:  Mech Dev       Date:  2011-01-21       Impact factor: 1.882

6.  MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7.

Authors:  Shireen Kahai; Shao-Chen Lee; Daniel Y Lee; Jennifer Yang; Minhui Li; Chia-Hui Wang; Zide Jiang; Yaou Zhang; Chun Peng; Burton B Yang
Journal:  PLoS One       Date:  2009-10-21       Impact factor: 3.240

7.  The up-regulation of microRNA-335 is associated with lipid metabolism in liver and white adipose tissue of genetically obese mice.

Authors:  Noriko Nakanishi; Yoshimi Nakagawa; Naoko Tokushige; Naohito Aoki; Takashi Matsuzaka; Kiyoaki Ishii; Naoya Yahagi; Kazuto Kobayashi; Shigeru Yatoh; Akimitsu Takahashi; Hiroaki Suzuki; Osamu Urayama; Nobuhiro Yamada; Hitoshi Shimano
Journal:  Biochem Biophys Res Commun       Date:  2009-05-19       Impact factor: 3.575

8.  Dicer is essential for mouse development.

Authors:  Emily Bernstein; Sang Yong Kim; Michelle A Carmell; Elizabeth P Murchison; Heather Alcorn; Mamie Z Li; Alea A Mills; Stephen J Elledge; Kathryn V Anderson; Gregory J Hannon
Journal:  Nat Genet       Date:  2003-10-05       Impact factor: 38.330

9.  Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes.

Authors:  Ginette Tardif; David Hum; Jean-Pierre Pelletier; Nicolas Duval; Johanne Martel-Pelletier
Journal:  BMC Musculoskelet Disord       Date:  2009-11-30       Impact factor: 2.362

Review 10.  Eph receptors and ephrin signaling pathways: a role in bone homeostasis.

Authors:  Claire M Edwards; Gregory R Mundy
Journal:  Int J Med Sci       Date:  2008-09-03       Impact factor: 3.738

View more
  216 in total

Review 1.  Mediators of inflammation and bone remodeling in rheumatic disease.

Authors:  Anita T Shaw; Ellen M Gravallese
Journal:  Semin Cell Dev Biol       Date:  2015-10-19       Impact factor: 7.727

Review 2.  MicroRNA variants as genetic determinants of bone mass.

Authors:  Neha S Dole; Anne M Delany
Journal:  Bone       Date:  2015-12-23       Impact factor: 4.398

3.  MicroRNA 874-3p Exerts Skeletal Anabolic Effects Epigenetically during Weaning by Suppressing Hdac1 Expression.

Authors:  Priyanka Kushwaha; Vikram Khedgikar; Deepika Sharma; Tony Yuen; Jyoti Gautam; Naseer Ahmad; Anirudha Karvande; Prabhat R Mishra; Prabodh K Trivedi; Li Sun; Sanjay K Bhadada; Mone Zaidi; Ritu Trivedi
Journal:  J Biol Chem       Date:  2015-12-09       Impact factor: 5.157

4.  Big endothelin changes the cellular miRNA environment in TMOb osteoblasts and increases mineralization.

Authors:  Michael G Johnson; Jasmin Kristianto; Baozhi Yuan; Kathryn Konicke; Robert Blank
Journal:  Connect Tissue Res       Date:  2014-08       Impact factor: 3.417

5.  A positive role of microRNA-15b on regulation of osteoblast differentiation.

Authors:  S Vimalraj; Nicola C Partridge; N Selvamurugan
Journal:  J Cell Physiol       Date:  2014-09       Impact factor: 6.384

Review 6.  MicroRNAs in the control of metastatic bone disease.

Authors:  Gillian Browne; Hanna Taipaleenmäki; Gary S Stein; Janet L Stein; Jane B Lian
Journal:  Trends Endocrinol Metab       Date:  2014-05-05       Impact factor: 12.015

Review 7.  Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies.

Authors:  Pierre J Marie
Journal:  Cell Mol Life Sci       Date:  2014-12-09       Impact factor: 9.261

Review 8.  Runx2 and microRNA regulation in bone and cartilage diseases.

Authors:  Weiwei Zhao; Shanxing Zhang; Baoli Wang; Jian Huang; William W Lu; Di Chen
Journal:  Ann N Y Acad Sci       Date:  2016-08-15       Impact factor: 5.691

9.  Enhancer of Zeste Homolog 2 Inhibition Stimulates Bone Formation and Mitigates Bone Loss Caused by Ovariectomy in Skeletally Mature Mice.

Authors:  Amel Dudakovic; Emily T Camilleri; Scott M Riester; Christopher R Paradise; Martina Gluscevic; Thomas M O'Toole; Roman Thaler; Jared M Evans; Huihuang Yan; Malayannan Subramaniam; John R Hawse; Gary S Stein; Martin A Montecino; Meghan E McGee-Lawrence; Jennifer J Westendorf; Andre J van Wijnen
Journal:  J Biol Chem       Date:  2016-10-10       Impact factor: 5.157

Review 10.  Genetic and molecular control of osterix in skeletal formation.

Authors:  Krishna M Sinha; Xin Zhou
Journal:  J Cell Biochem       Date:  2013-05       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.